ACSS2 is required for colorectal cancer progression and a druggable target for colorectal cancer treatment.

Saved in:
Bibliographic Details
Title: ACSS2 is required for colorectal cancer progression and a druggable target for colorectal cancer treatment.
Authors: Wang L; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., Dougherty U; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., He W; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., Gao L; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., Muefong C; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., Sarkar R; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., Du J; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., Shergill A; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., Lin H; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.; Department of Chemistry, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.; Howard Hughes Medical Institute, The University of Chicago, Chicago, IL, USA., Bissonnette M; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA., Li YC; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.; Committee on Molecular Metabolism and Nutrition, The University of Chicago, Chicago, IL, USA.
Source: IScience [iScience] 2026 Jul 21; Vol. 29 (8), pp. 116860. Date of Electronic Publication: 2026 Jul 21 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-0042
DOI:10.1016/j.isci.2026.116860